Literature DB >> 18617583

Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.

N-J Rim1, H S Kim, Y S Shin, S Y Kim.   

Abstract

BACKGROUND AND
PURPOSE: CT perfusion (CTP) is a more readily accessible method for evaluation of cerebral perfusion than single-photon emission CT (SPECT). We assessed whether there is any resting or drug-challenged CTP parameter correlating with cerebrovascular reserve (CVR) obtained by SPECT in Moyamoya patients.
MATERIALS AND METHODS: Normalized baseline CTP parameters and their percentage changes were calculated in 152 regions of interest (ROIs). On qualitative SPECT analysis, each ROI was classified in either the "impaired CVR" or "normal CVR" group. Quantitative CVR was calculated by using normalized SPECT values before and after acetazolamide administration. Baseline CTP parameters and their percentage changes were compared with qualitative and quantitative CVRs. Receiver operating characteristic (ROC) curve analysis defined the threshold values of CTP parameters that best predict impaired qualitative CVR.
RESULTS: The mean values of CTP parameters were significantly different between normal and impaired CVR groups. The percentage change of cerebral blood flow (pcCBF) was correlated most significantly with quantitative CVR (r = 0.89; P < .05). The correlation coefficients between the baseline CTP parameters and quantitative CVR were poor or not significant. The ROC-derived threshold values of pcCBF and mean transit time determined impaired CVR with a sensitivity of 94.4 and 85.2; specificity of 93.2 and 65.9; positive predictive value of 97.1 and 86.0; and negative predictive value of 87.2 and 64.4, respectively.
CONCLUSION: Baseline CTP parameters are not reliable for predicting impaired CVR. However, pcCBF correlated strongly with quantitative CVR; therefore, CTP evaluation for CVR in Moyamoya patients requires normalization and acetazolamide challenge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617583      PMCID: PMC8118762          DOI: 10.3174/ajnr.A1229

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease.

Authors:  James D Eastwood; Michael J Alexander; Jeffrey R Petrella; James M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

2.  The effect of deafferentation on cerebral blood flow response to acetazolamide.

Authors:  Hiroshi Yamauchi; Hidehiko Okazawa; Kanji Sugimoto; Yoshihiko Kishibe; Masaaki Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

3.  Variability of the territories of the major cerebral arteries.

Authors:  A van der Zwan; B Hillen; C A Tulleken; M Dujovny; L Dragovic
Journal:  J Neurosurg       Date:  1992-12       Impact factor: 5.115

4.  Defining a local arterial input function for perfusion MRI using independent component analysis.

Authors:  Fernando Calamante; Morten Mørup; Lars Kai Hansen
Journal:  Magn Reson Med       Date:  2004-10       Impact factor: 4.668

5.  Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography.

Authors:  Hidehiko Endo; Takashi Inoue; Kuniaki Ogasawara; Takeshi Fukuda; Yoshiyuki Kanbara; Akira Ogawa
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

Review 6.  Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models.

Authors:  M Wintermark; P Maeder; J P Thiran; P Schnyder; R Meuli
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

7.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

8.  Validation of the CBF, CBV, and MTT values by perfusion MRI in chronic occlusive cerebrovascular disease: a comparison with 15O-PET.

Authors:  Koichiro Kaneko; Yasuo Kuwabara; Futoshi Mihara; Takashi Yoshiura; Makoto Nakagawa; Atsuo Tanaka; Masayuki Sasaki; Hirofumi Koga; Kazutaka Hayashi; Hiroshi Honda
Journal:  Acad Radiol       Date:  2004-05       Impact factor: 3.173

9.  Cerebrovascular reactivity to acetazolamide in carotid artery disease. Enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure.

Authors:  T Schroeder
Journal:  Neurol Res       Date:  1986-12       Impact factor: 2.448

10.  Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.

Authors:  T Nariai; R Suzuki; K Hirakawa; T Maehara; K Ishii; M Senda
Journal:  AJNR Am J Neuroradiol       Date:  1995-03       Impact factor: 3.825

View more
  15 in total

Review 1.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

2.  Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test.

Authors:  David Y T Chen; Yosuke Ishii; Audrey P Fan; Jia Guo; Moss Y Zhao; Gary K Steinberg; Greg Zaharchuk
Journal:  Radiology       Date:  2020-07-14       Impact factor: 11.105

3.  CTA-enhanced perfusion CT: an original method to perform ultra-low-dose CTA-enhanced perfusion CT.

Authors:  Elizabeth Tong; Max Wintermark
Journal:  Neuroradiology       Date:  2014-08-02       Impact factor: 2.804

4.  CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).

Authors:  Yueqin Chen; Wenjian Xu; Xiang Guo; Zhitao Shi; Zhanguo Sun; Lingyun Gao; Feng Jin; Jiehuan Wang; Weijian Chen; Yunjun Yang
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

5.  Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA).

Authors:  Norberto Andaluz; Ondrej Choutka; Achala Vagal; Rhonda Strunk; Mario Zuccarello
Journal:  Neurosurg Rev       Date:  2010-02-06       Impact factor: 3.042

Review 6.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

7.  Simultaneous multi-slice (SMS) acquisition enhances the sensitivity of hemodynamic mapping using gas challenges.

Authors:  Harshan Ravi; Peiying Liu; Shin-Lei Peng; Hanli Liu; Hanzhang Lu
Journal:  NMR Biomed       Date:  2016-09-06       Impact factor: 4.044

Review 8.  Evaluation of CT perfusion in the setting of cerebral ischemia: patterns and pitfalls.

Authors:  Y W Lui; E R Tang; A M Allmendinger; V Spektor
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-25       Impact factor: 3.825

9.  Stenotic transverse sinus predisposes to poststenting hyperperfusion syndrome as evidenced by quantitative analysis of peritherapeutic cerebral circulation time.

Authors:  C-J Lin; F-C Chang; F-Y Tsai; W-Y Guo; S-C Hung; D Y-T Chen; C-H Lin; C-Y Chang
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-16       Impact factor: 3.825

10.  Prediction of cerebral hyperperfusion syndrome after carotid artery stenting by CT perfusion imaging with acetazolamide challenge.

Authors:  Tomohide Yoshie; Toshihiro Ueda; Tatsuro Takada; Shinji Nogoshi; Takayuki Fukano; Yasuhiro Hasegawa
Journal:  Neuroradiology       Date:  2015-12-02       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.